These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 2689092

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Angiotensin-converting enzyme inhibition in diabetic nephropathy: ten years' experience.
    Parving HH, Rossing P, Hommel E, Smidt UM.
    Am J Kidney Dis; 1995 Jul; 26(1):99-107. PubMed ID: 7611276
    [Abstract] [Full Text] [Related]

  • 3. Nephropathy in model combining genetic hypertension with experimental diabetes. Enalapril versus hydralazine and metoprolol therapy.
    Cooper ME, Allen TJ, O'Brien RC, Papazoglou D, Clarke BE, Jerums G, Doyle AE.
    Diabetes; 1990 Dec; 39(12):1575-9. PubMed ID: 2245881
    [Abstract] [Full Text] [Related]

  • 4. Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy.
    Parving HH, Hommel E, Smidt UM.
    BMJ; 1988 Oct 29; 297(6656):1086-91. PubMed ID: 3143437
    [Abstract] [Full Text] [Related]

  • 5. Long-term beneficial effect of ACE inhibition on diabetic nephropathy in normotensive type 1 diabetic patients.
    Parving HH, Hommel E, Jensen BR, Hansen HP.
    Kidney Int; 2001 Jul 29; 60(1):228-34. PubMed ID: 11422755
    [Abstract] [Full Text] [Related]

  • 6. Influence of converting enzyme inhibition on glomerular filtration rate and proteinuria.
    Rodicio JL, Alcazar JM, Ruilope LM.
    Kidney Int; 1990 Oct 29; 38(4):590-4. PubMed ID: 2232500
    [No Abstract] [Full Text] [Related]

  • 7. ACE-inhibition and renoprotection in early diabetic nephropathy. Response to enalapril acutely and in long-term combination with conventional antihypertensive treatment.
    Pedersen MM, Christensen CK, Hansen KW, Christiansen JS, Mogensen CE.
    Clin Invest Med; 1991 Dec 29; 14(6):642-51. PubMed ID: 1665407
    [Abstract] [Full Text] [Related]

  • 8. Reduction in albuminuria predicts a beneficial effect on diminishing the progression of human diabetic nephropathy during antihypertensive treatment.
    Rossing P, Hommel E, Smidt UM, Parving HH.
    Diabetologia; 1994 May 29; 37(5):511-6. PubMed ID: 8056190
    [Abstract] [Full Text] [Related]

  • 9. Effect of captopril on blood pressure and kidney function in normotensive insulin dependent diabetics with nephropathy.
    Parving HH, Hommel E, Damkjaer Nielsen M, Giese J.
    BMJ; 1989 Aug 26; 299(6698):533-6. PubMed ID: 2507061
    [Abstract] [Full Text] [Related]

  • 10. Combining antihypertensive agents in early diabetic nephropathy.
    Christensen CK, Pedersen MM, Mogensen CE.
    J Diabet Complications; 1990 Aug 26; 4(2):88-90. PubMed ID: 2145311
    [No Abstract] [Full Text] [Related]

  • 11. [Nephropathy in type 1 diabetes mellitus. Current experimental and clinical aspects].
    Teschner M, Schaefer RM, Bahner U, Heidland A.
    Dtsch Med Wochenschr; 1992 Nov 06; 117(45):1730-4. PubMed ID: 1425285
    [No Abstract] [Full Text] [Related]

  • 12. Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy.
    Björck S, Nyberg G, Mulec H, Granerus G, Herlitz H, Aurell M.
    Br Med J (Clin Res Ed); 1986 Aug 23; 293(6545):471-4. PubMed ID: 3017501
    [Abstract] [Full Text] [Related]

  • 13. Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study.
    Parving HH, Jacobsen P, Tarnow L, Rossing P, Lecerf L, Poirier O, Cambien F.
    BMJ; 1996 Sep 07; 313(7057):591-4. PubMed ID: 8806248
    [Abstract] [Full Text] [Related]

  • 14. Diabetes and hypertension.
    Mogensen CE.
    Lancet; 1979 Feb 17; 1(8112):388-9. PubMed ID: 85044
    [No Abstract] [Full Text] [Related]

  • 15. Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy.
    Parving HH, Andersen AR, Smidt UM, Svendsen PA.
    Lancet; 1983 May 28; 1(8335):1175-9. PubMed ID: 6133986
    [Abstract] [Full Text] [Related]

  • 16. Enalapril retards glomerular basement membrane thickening and albuminuria in the diabetic rat: are these effects specific for enalapril?
    Baba T, Sawicki PT.
    Diabetologia; 1989 Nov 28; 32(11):829. PubMed ID: 2556309
    [No Abstract] [Full Text] [Related]

  • 17. Short and long term effects of antihypertensive therapy in the diabetic rat.
    Anderson S, Rennke HG, Garcia DL, Brenner BM.
    Kidney Int; 1989 Oct 28; 36(4):526-36. PubMed ID: 2681929
    [Abstract] [Full Text] [Related]

  • 18. Glomerular abnormalities in long-term experimental diabetes. Role of hemodynamic and nonhemodynamic factors and effects of antihypertensive therapy.
    Fujihara CK, Padilha RM, Zatz R.
    Diabetes; 1992 Mar 28; 41(3):286-93. PubMed ID: 1551488
    [Abstract] [Full Text] [Related]

  • 19. Renal protective effect of enalapril in diabetic nephropathy.
    Björck S, Mulec H, Johnsen SA, Nordén G, Aurell M.
    BMJ; 1992 Feb 08; 304(6823):339-43. PubMed ID: 1540729
    [Abstract] [Full Text] [Related]

  • 20. Captopril and atenolol are equally effective in retarding progression of diabetic nephropathy. Results of a 2-year prospective, randomized study.
    Elving LD, Wetzels JF, van Lier HJ, de Nobel E, Berden JH.
    Diabetologia; 1994 Jun 08; 37(6):604-9. PubMed ID: 7926346
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.